期刊
JOURNAL OF MEDICAL VIROLOGY
卷 93, 期 6, 页码 3508-3515出版社
WILEY
DOI: 10.1002/jmv.26779
关键词
epitope peptide; hemagglutinin; influenza virus; monoclonal antibody; neutralizing
类别
资金
- Natural Science Foundation of Shaanxi Province [2020JM655, 2020JM-662]
This study evaluated the neutralizing and hemagglutination inhibition activity of a murine anti-H1N1 monoclonal antibody, and identified its epitope peptide through phage display technique. The identified epitope contains key amino acids for sialic acid receptor binding in HA, contributing to the production of neutralizing antibodies.
Influenza virus cause seasonal influenza epidemic and seriously sporadic influenza pandemic outbreaks. Hemagglutinin (HA) is an important target in the therapeutic treatment and diagnostic detection of the influenza virus. Variation in the sialic acid receptor binding site leads to strain-specific binding and results in different binding modes to the host receptors. Here, we evaluated the neutralizing activity and hemagglutination inhibition activity of a prepared murine anti-H1N1 monoclonal antibody PR8-23. Then we identified the epitope peptide of antibody PR8-23 by phage display technique from phage display peptide libraries. The identified epitope, 63-IAPLQLGKCNIA-74, containing two alpha-helix and two beta-fold located at the footprint of the sialoglycan receptor on the RBS in the globular head domain of HA. It broads the growing arsenal of motifs for the amino acids on the globular head domain of HA in sialic acid receptor binding site and neutralizing antibody production.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据